Effects of interaction between genetic variants in human leukocyte antigen DQ and granulysin genes in Chinese Han subjects infected with hepatitis B virus

Microbiology and Immunology

Volumn 59, Issue 4, 2015, Pages 209-218

  Hou, Si Hui ^a   Hu, Jun ^a   Zhang, Yu ^a   Li, Qing Ling ^b   Guo, Jin Jun ^a  

^a THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Granulysin; Hepatitis B virus; Human leukocyte antigen; Single nucleotide polymorphisms

Indexed keywords

GENOMIC DNA; GRANULYSIN; HLA DQ ANTIGEN; GNLY PROTEIN, HUMAN; T LYMPHOCYTE ANTIGEN;

ADULT; ARTICLE; CHINESE; CHRONIC LIVER DISEASE; FEMALE; GENE IDENTIFICATION; GENE INTERACTION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GRANULYSIN GENE; HAPLOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HLA DQ GENE; HUMAN; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CHINA; COHORT ANALYSIS; EPISTASIS; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY; VIROLOGY; YOUNG ADULT;

HEPATITIS B VIRUS;

ADULT; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; COHORT STUDIES; EPISTASIS, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HEPATITIS B; HEPATITIS B VIRUS; HLA-DQ ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84927710053     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/1348-0421.12239     Document Type: Article

References (44)

1. Kew M.C. (2010) Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol (Paris) 58: 273-7.
2. Taylor B.C., Yuan J.M., Shamliyan T.A., Shaukat A., Kane R.L., Wilt T.J. (2009) Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: a systematic review of evidence. Hepatology 49: S85-95.
3. European Association for the Study of the Liver. (2012) EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 57: 167-85.
4. Chotiyaputta W., Lok A.S. (2009) Hepatitis B virus variants. Nat Rev Gastroenterol Hepatol 6: 453-62.
5. Huang Y., Lok A.S. (2011) Viral factors and outcomes of chronic HBV infection. Am J Gastroenterol 106: 93-5.
6. Thursz M., Yee L., Khakoo S. (2011) Understanding the host genetics of chronic hepatitis B and C. Semin Liver Dis 31: 115-27.
7. Abbas Z., Siddiqui A.R. (2011) Management of hepatitis B in developing countries. World J Hepatol 3: 292-9.
8. Yapali S., Talaa, N., Lok A. S. (2014) Management of hepatitis B: our practice and how it relates to the guidelines. Clin Gastroenterol Hepatol 12: 16-26.
9. Loggi E., Gamal N., Bihl F., Bernardi M., Andreone P. (2014) Adaptive response in hepatitis B virus infection. J Viral Hepat 21: 305-13.
10. Pan L., Zhang L., Zhang W., Wu X., Li Y., Yan B., Zhu X., Liu X., Yang C., Xu J., Zhou G., Xu A., Li H., Liu Y. (2014) A genome-wide association study identifies polymorphisms in the HLA-DR region associated with non-response to hepatitis B vaccination in Chinese Han populations. Hum Mol Genet 23: 2210-9.
11. Jiang D.K., Sun J., Cao G., Liu Y., Lin D., Gao Y.Z., Ren W.H., Long X.D., Zhang H., Ma X.P., Wang Z., Jiang W., Chen T.Y., Gao Y., Sun L.D., Long J.R., Huang H.X., Wang D., Yu H., Zhang P., Tang L.S., Peng B., Cai H., Liu T. T., Zhou P., Liu F., Lin X., Tao S., Wan B., Sai-Yin H.X., Qin L.X., Yin J., Liu L., Wu C., Pei Y., Zhou Y.F., Zhai Y., Lu P. X., Tan A., Zuo X.B., Fan J., Chang J., Gu X., Wang N.J., Li Y., Liu Y.K., Zhai K., Zhang H., Hu Z., Liu J., Yi Q., Xiang Y., Shi R., Ding Q., Zheng W., Shu X.O., Mo Z., Shugart Y.Y., Zhang X.J., Zhou G., Shen H., Zheng S.L., Xu J., Yu, L. (2013) Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet 45: 72-5.
12. Nishida N., Sawai H., Matsuura K., Sugiyama M., Ahn S.H., Park J. Y., Hige S., Kang J.H., Suzuki K., Kurosaki M., Asahina Y., Mochida S., Watanabe M., Tanaka E., Honda M., Kaneko S., Orito E., Itoh Y., Mita E., Tamori A., Murawaki Y., Hiasa Y., Sakaida I., Korenaga M., Hino K., Ide T., Kawashima M., Mawatari Y., Sageshima M., Ogasawara Y., Koike A., Izumi N., Han K.H., Tanaka Y., Tokunaga K., Mizokami M. (2012) Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. PLoS ONE 7: e39175.
13. Hu L., Zhai X., Liu J., Chu M., Pan S., Jiang J., Zhang Y., Wang H., Chen J., Shen H., Hu Z. (2012) Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology 55: 1426-31.
14. Kamatani Y., Wattanapokayakit S., Ochi H., Kawaguchi T., Takahashi A., Hosono N., Kubo M., Tsunoda T., Kamatani N., Kumada H., Puseenam A., Sura T., Daigo Y., Chayama K., Chantratita W., Nakamura Y., Matsuda K. (2009) A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 41: 591-5.
15. Mbarek H., Ochi H., Urabe Y., Kumar V., Kubo M., Hosono N., Takahashi A., Kamatani Y., Miki D., Abe H., Tsunoda T., Kamatani N., Chayama K., Nakamura Y., Matsuda K. (2011) A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum Mol Genet 20: 3884-92.
16. Kumar V., Kato N., Urabe Y., Takahashi A., Muroyama R., Hosono N., Otsuka M., Tateishi R., Omata M., Nakagawa H., Koike K., Kamatani N., Kubo M., Nakamura Y., Matsuda K. (2011) Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. Nat Genet 43: 455-8.
17. Al-Qahtani A.A., Al-Anazi M.R., Abdo A.A., Sanai F.M., Al-Hamoudi W., Alswat K.A., Al-Ashgar H.I., Khalaf N.Z., Eldali A.M., Viswan N.A., Al-Ahdal M.N. (2014) Association between HLA variations and chronic hepatitis B virus infection in Saudi Arabian patients. PLoS ONE 9: e80445.
18. Zhang X., Jia J., Dong J., Yu F., Ma N., Li M., Liu X., Liu W., Li T., Liu D. (2014) HLA-DQ polymorphisms with HBV infection: different outcomes upon infection and prognosis to lamivudine therapy. J Viral Hepat 21: 491-8.
19. Pena S.V., Hanson D.A., Carr B.A., Goralski T.J., Krensky A.M. (1997) Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J Immunol 158: 2680-8.
20. Pena S.V., Krensky A.M. (1997) Granulysin, ;1; a new human cytolytic granule-associated protein with possible involvement in cell-mediated cytotoxicity. Semin Immunol 9: 117-25.
21. Stenger S., Hanson D.A., Teitelbaum R., Dewan P., Niazi K.R., Froelich C.J., Ganz T., Thoma-Uszynski S., Melian A., Bogdan C., Porcelli S.A., Bloom B.R., Krensky A.M., Modlin R.L. (1998) An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282: 121-5.
22. Ducic I., Shalom A., Rising W., Nagamoto K., Munster A.M. (2002) Outcome of patients with toxic epidermal necrolysis syndrome revisited. Plast Reconstr Surg 110: 768-73.
23. Park G.H., Kim K.Y., Cheong J.Y., Cho S.W., Kwack K. (2012) Association of GNLY genetic polymorphisms with chronic liver disease in a Korean population. DNA Cell Biol 31: 1492-8.
24. Zuk O., Hechter E., Sunyaev S.R., Lander E.S. (2012) The mystery of missing heritability: genetic interactions create phantom heritability. Proc Natl Acad Sci USA 109: 1193-8.
25. Eichler E.E., Flint J., Gibson G., Kong A., Leal S.M., Moore J.H., Nadeau J.H. (2010) Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 11: 446-50.
26. Seto W.K., Wong D.K., Kopaniszen M., Proitsi P., Sham P.C., Hung I.F., Fung J., Lai C.L., Yuen M.F. (2013) HLA-DP and IL28B polymorphisms: influence of host genome on hepatitis B surface antigen seroclearance in chronic hepatitis B. Clin Infect Dis 56: 1695-703.
27. International HapMap project. International HapMap project. [Cited] (2010) Available from URL: http://hapmap.ncbi.nlm.nih.gov.
28. Broad Institute. Haploview. [Cited] (2009) Available from URL: http://www.broad.mit.edu/haploview/haploview.
29. Barrett J.C., Fry B., Maller J., Daly M.J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-5.
30. Queen's University. F-SNP: a collection of functional SNPs, specifically prioritized for disease association studies. [Cited] (2008) Available from URL: http://compbio.cs.queensu.ca/F-SNP/.
31. National Institutes of Health. National Institute of Environmental Health Sciences. [Cited] (2009) Available from URL: http://snpinfo.niehs.nih.gov/.
32. Lee P.H., Shatkay H. (2008) F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res 36: D820-4.
33. Xu Z., Taylor J.A. (2009) SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res 37: W600-5.
34. Helmholtz Center Munich. Genetic statistics, case-control studies. (2014) Available from URL: http://ihg.gsf.de/ihg/snps.html.
35. Ritchie M.D., Hahn L.W., Roodi N., Bailey L.R., Dupont W.D., Parl F.F., Moore J.H. (2001) Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69: 138-47.
36. Blackwell J.M., Jamieson S.E., Burgner D. (2009) HLA and infectious diseases. Clin Microbiol Rev 22: 370-385.
37. Godkin A., Davenport M., Hill A.V. (2005) Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology 41: 1383-90.
38. Saini R.V., Wilson C., Finn M.W., Wang T., Krensky A.M., Clayberger C. (2011) Granulysin delivered by cytotoxic cells damages endoplasmic reticulum and activates caspase-7 in target cells. J Immunol 186: 3497-504.
39. Andersson J., Samarina A., Fink J., Rahman S., Grundstrom S. (2007) Impaired expression of perforin and granulysin in CD8+ T cells at the site of infection in human chronic pulmonary tuberculosis. Infect Immun 75: 5210-22.
40. Chung W.H., Hung S.I. (2010) Genetic markers and danger signals in Stevens-Johnson syndrome and toxic epidermal necrolysis. Allergol Int 59: 325-32.
41. Pitabut N., Sakurada S., Tanaka T., Ridruechai C., Tanuma J., Aoki T., Kantipong P., Piyaworawong S., Kobayashi N., Dhepakson P., Yanai H., Yamada N., Oka S., Okada M., Khusmith S., Keicho N. (2013) Potential function of granulysin, ;1; other related effector molecules and lymphocyte subsets in patients with TB and HIV/TB coinfection. Int J Med Sci 10: 1003-14.
42. Wang S.H., Yeh S.H., Lin W.H., Wang H.Y., Chen D.S., Chen P.J. (2009) Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B. Hepatology 50: 1392-402.
43. Ober C., Loisel D.A., Gilad Y. (2008) Sex-specific genetic architecture of human disease. Nat Rev Genet 9: 911-22.
44. Hewagama A., Patel D., Yarlagadda S., Strickland F.M., Richardson B.C. (2009) Stronger inflammatory/cytotoxic T-cell response in women identified by microarray analysis. Genes Immun 10: 509-16.